AKS-452 fusion protein vaccine

AKS-452 fusion protein vaccine · University Medical Center Groningen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AKS-452 fusion protein vaccine, covering 2024-04-16 to 2024-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Anti-COVID19 AKS-452 Fusion Protein Vaccine - ACT Study [Phase 1, Phase 2]